Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies.

Cancer science - 1 Apr 2015

Harada Hironori, Harada Yuka

Abstract excerpt

Myelodysplastic syndromes (MDS) are defined as stem cell disorders caused by various gene abnormalities. Recent analysis using next-generation sequencing has provided great advances in identifying relationships between gene mutations and clinical phenotypes of MDS. Gene mutations affecting RNA splicing machinery, DNA methylation, histone modifications, transcription factors, signal transduction proteins and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Assembly and Disassembly
Share to Core Binding Factor Alpha 2 Subunit

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Molecular Targeted Therapy

Share to Myelodysplastic Syndromes

Share to RNA Splicing

Share to Stem Cells

Share to Transcription, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 25611784
DOI: 10.1111/cas.12614
PMCID: PMC4409874

Genes

RUNX1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies.PMID 25611784Read ↗

The genetics of myelodysplastic syndromes and the opportunities for tailored treatmentsSemantic proximity Read ↗

Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes.Semantic proximity Read ↗

MDS: Recent progress in molecular pathogenesis and clinical aspects.Semantic proximity Read ↗

Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.Semantic proximity Read ↗

Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.Semantic proximity Read ↗

New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.Semantic proximity Read ↗

Pathophysiology of MDS: genomic aberrations.Semantic proximity Read ↗

Molecular pathophysiology of myelodysplastic syndromes.Semantic proximity Read ↗

The genetic basis of myelodysplasia and its clinical relevance.Semantic proximity Read ↗

Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolutionSemantic proximity Read ↗

The genetic and molecular pathogenesis of myelodysplastic syndromes.Semantic proximity Read ↗

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.